Detection of Pulmonary Toxoplasma gondii Causing Atypical Pneumonia in an Immunosuppressed Patient through Metagenomic Sequencing
Authors:
- Jaime David Acosta-EspañaJAJaime David Acosta-España
- Jorge Andrés González GrijalvaJGJorge Andrés González Grijalva
- Diego Fernando Paredes VinuezaDVDiego Fernando Paredes Vinueza
- Maria Margarita Guaman VizhañayMVMaria Margarita Guaman Vizhañay
- Alexander MaldonadoAMAlexander Maldonado
- Andrés Herrera-YelaAHAndrés Herrera-Yela
Preprint
- 23 June 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background Pulmonary toxoplasmosis is a rare but critical opportunistic infection in immunosuppressed individuals, often presenting as atypical pneumonia. Conventional diagnostic methods, including serology and cultures, may yield false negatives, complicating timely diagnosis and treatment. Methods: A bronchoalveolar lavage sample was obtained from a 48-year-old immunosuppressed patient hospitalized with atypical pneumonia. The sample underwent next-generation sequencing (NGS)-based metagenomic analysis, including nucleic acid extraction, library preparation, high-throughput sequencing, and bioinformatic pipeline processing for microbial identification. Results: NGS identified Toxoplasma gondii DNA in the bronchoalveolar lavage sample, confirming a diagnosis of pulmonary toxoplasmosis. Remarkably, the patient responded clinically to metronidazole monotherapy, achieving significant symptom resolution. Follow-up computed tomography revealed complete radiological improvement, confirming clinical cure. Discussion: This case underscores the value of metagenomic sequencing in diagnosing atypical pathogens where conventional approaches fail. The identification of Toxoplasma gondii highlights the expanded utility of NGS in pulmonary infections, particularly in immunosuppressed patients. The unexpected success of metronidazole as a sole treatment raises questions about its potential efficacy against Toxoplasma gondii, warranting further investigation. Conclusion: Metagenomic diagnostics represent a powerful tool in identifying rare infectious agents and guiding effective interventions. This case highlights the clinical significance of NGS in improving diagnostic precision and broadening therapeutic horizons for pulmonary toxoplasmosis.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Metagenomic next-generation sequencing as a diagnostic tool in the clinical routine of an infectious diseases department: a retrospective cohort studyInfection, 2024
- The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 updateNucleic Acids Research, 2024
- Analysis and Interpretation of metagenomics data: an approachBiological Procedures Online, 2022
- Clinical metagenomicsNature Reviews Genetics, 2019
- Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious DiseasesClinical Infectious Diseases, 2017
- Significant Reduction of Brain Cysts Caused by Toxoplasma gondii after Treatment with Spiramycin Coadministered with Metronidazole in a Mouse Model of Chronic ToxoplasmosisAntimicrobial Agents and Chemotherapy, 2012
- Interactive metagenomic visualization in a Web browserBMC Bioinformatics, 2011
- EuPathDB: a portal to eukaryotic pathogen databasesNucleic Acids Research, 2009
- Pulmonary toxoplasmosis in immunocompromised patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin AAntimicrobial Agents and Chemotherapy, 1984